(Q54448748)

English

VEGFR1 single nucleotide polymorphisms associated with outcome in patients with metastatic renal cell carcinoma treated with sunitinib - a multicentric retrospective analysis.

scientific article published on 20 February 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23421954

VEGFR1 single nucleotide polymorphisms associated with outcome in patients with metastatic renal cell carcinoma treated with sunitinib - a multicentric retrospective analysis. (English)

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23421954

single-nucleotide polymorphism

1 reference

based on heuristic

inferred from title

renal cell carcinoma

1 reference

based on heuristic

inferred from title

metastatic renal cell carcinoma

1 reference

based on heuristic

inferred from title

Benoit Beuselinck

1

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23421954

Aurélien Descazeaud

18

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23421954

Jean-Jacques Patard

21

object named as

Jean-Jacques Patard

1 reference

Europe PubMed Central

29 May 2018

Diether Lambrechts

3

object named as

Diether Lambrechts

1 reference

Europe PubMed Central

29 May 2018

Patrick Schöffski

10

object named as

Patrick Schöffski

1 reference

Europe PubMed Central

29 May 2018

author name string

Alexandra Karadimou

2

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23421954

Bart Claes

4

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23421954

Pascal Wolter

5

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23421954

Gabrielle Couchy

6

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23421954

Joost Berkers

7

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23421954

Hendrik van Poppel

8

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23421954

Robert Paridaens

9

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23421954

Arnaud Méjean

11

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23421954

Virginie Verkarre

12

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23421954

Evelyne Lerut

13

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23421954

Florence Joly

14

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23421954

Thierry Lebret

15

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23421954

Gwénaelle Gravis

16

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23421954

Gael Deplanque

17

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23421954

Nathalie Rioux Leclercq

19

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23421954

Vincent Molinié

20

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23421954

Corine Teghom

22

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23421954

Reza Elaidi

23

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23421954

Jessica Zucman-Rossi

24

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23421954

Stéphane Oudard

25

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23421954

publication date

20 February 2013

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23421954

Acta Oncologica

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23421954

53

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23421954

1

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23421954

103-112

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23421954

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770600

21 January 2018

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770600

21 January 2018

Resistance to targeted therapy in renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770600

21 January 2018

Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770600

21 January 2018

Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770600

21 January 2018

Pazopanib efficacy in renal cell carcinoma: evidence for predictive genetic markers in angiogenesis-related and exposure-related genes.

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770600

21 January 2018

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770600

21 January 2018

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770600

21 January 2018

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770600

21 January 2018

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770600

21 January 2018

Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770600

21 January 2018

VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770600

21 January 2018

The predictive value of single nucleotide polymorphisms in the VEGF system to the efficacy of first-line treatment with bevacizumab plus chemotherapy in patients with metastatic colorectal cancer: results from the Nordic ACT trial.

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770600

21 January 2018

Optimized filtering reduces the error rate in detecting genomic variants by short-read sequencing.

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770600

21 January 2018

Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinib.

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770600

21 January 2018

Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2013.770600

21 January 2018

Identifiers

10.3109/0284186X.2013.770600

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23421954

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/23421954

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54448748&oldid=1531330061"